echocardiogram) may be expected to facilitate the identification of patients with chest pain of
an ischemic etiology (angina). In a patient presenting to the emergency department with …

Biomarkers are biological parameters that can be objectively measured and quantified as
indicators of normal biologic processes, pathogenic processes, or responses to a …

Purpose Acute myocardial infarction (AMI) is the most common cause of death in the world.
Comprehensive risk assessment of patients presenting with chest pain and eliminating …

The investigation of novel circulating serum and plasma biomarkers in patients with
cardiovascular disease has been accelerating at a remarkable pace. For example, a …

Biomarkers, broadly defined, are markers of a biological process or state. 1 Biomarkers are
often used in research studies, but they may also be useful for clinicians and patients if they …

Cardiovascular diseases are the leading causes of mortality worldwide. Among them,
hypertension and its pathological complications pose a major risk for the development of …

The primary prevention of cardiovascular disease relies on the ability to identify at‐risk
individuals long before the development of overt events. In the past decade, research into …

A biomarker is a characteristic that can be objectively measured and evaluated as an
indicator of normal biological processes, pathogenic processes or pharmacological …

Cardiovascular biomarker research efforts have resulted in the identification of new risk
factors and novel drug targets, as well as the establishment of treatment guidelines …

With 8 million patients arriving with nontraumatic chest pain to emergency departments in
the US each year, the clinical evaluation, triage, and management of patients with possible …